Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline
The aim of this guideline is to present recommendations regarding moderately hypofractionated (240-340 cGy per fraction) and ultrahypofractionated (500 cGy or more per fraction) radiation therapy for localized prostate cancer.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Scott C. Morgan, Karen Hoffman, D. Andrew Loblaw, Mark K. Buyyounouski, Caroline Patton, Daniel Barocas, Soren Bentzen, Michael Chang, Jason Efstathiou, Patrick Greany, Per Halvorsen, Bridget F. Koontz, Colleen Lawton, C. Marc Leyrer, Daniel Lin, Michael Source Type: research
More News: Cancer | Cancer & Oncology | Legislation | Prostate Cancer | Radiation Therapy | Urology & Nephrology